Routine

Assessment for kidney transplantation (recipient work-up)

transplant work-up · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Systematic evaluation of CKD patients approaching end-stage kidney disease for suitability and safety of transplantation, ideally pre-emptively before dialysis. Identifies cardiovascular, infective, malignancy and immunological barriers and sensitises patients to living-donor options.

Red flags

  • Active malignancy or recent cancer without adequate disease-free interval
  • Active untreated infection (including TB, hepatitis)
  • Severe untreatable cardiac disease
  • Very high sensitisation (high cPRA) limiting donor options
  • Ongoing non-adherence or unmanaged substance misuse

Assessment

Differential diagnosis

  • Suitable candidate (standard risk)
  • High cardiovascular risk candidate
  • Active malignancy (contraindication until treated/cleared)
  • Active/chronic infection
  • Highly sensitised (high cPRA) candidate
  • Candidate for living vs deceased donor transplant

Investigations

  • Blood group and HLA typing, calculated panel-reactive antibody (cPRA) and DSA screen
  • Virology: HIV, hepatitis B/C, CMV, EBV serology
  • Cardiac assessment (ECG, echo, functional/ischaemia testing for high-risk)
  • Malignancy screening appropriate to age/risk; dental and skin review
  • Renal tract imaging and bladder/urological assessment
  • Comorbidity work-up (diabetes control, nutrition, frailty, infection screen incl. TB)

Management

  • Refer CKD patients early (eGFR ~15-20 or progressing) for pre-emptive assessment before dialysis
  • Confirm the patient is likely to benefit and can tolerate surgery and immunosuppression
  • Perform immunological work-up: blood group, HLA type, cPRA/sensitisation and DSA; identify crossmatch needs
  • Complete infection screen (HIV, hepatitis B/C, CMV, EBV, TB) and update vaccinations before immunosuppression
  • Risk-stratify cardiovascular disease and arrange functional cardiac testing/optimisation in high-risk patients
  • Screen for malignancy and ensure any active cancer is treated with an appropriate disease-free interval
  • Assess the lower urinary tract/bladder and vascular anatomy for surgical feasibility
  • Address modifiable risks: smoking cessation, weight optimisation, glycaemic and BP control, dental clearance
  • Explore and promote living-donor transplantation (best outcomes) and paired-exchange for sensitised patients
  • Counsel on risks/benefits, immunosuppression and lifelong follow-up; obtain informed consent
  • Place suitable candidates on the deceased-donor waiting list and keep antibody screening current
  • Re-evaluate periodically while waiting, updating cardiac, infective and sensitisation status

Drugs & doses

Hepatitis B vaccination course (e.g. 40 micrograms IM at 0, 1, 2, 6 months in CKD/dialysis)
Update inactivated vaccines (influenza, pneumococcal, SARS-CoV-2) before transplant; avoid live vaccines close to transplant
Statin and antihypertensive optimisation per cardiovascular risk

Disposition

Outpatient transplant assessment clinic with cardiology, surgery and immunology input. List suitable candidates; pursue living-donor options. Periodic re-evaluation while waiting.

Complications & pitfalls

  • Perioperative cardiovascular events
  • Post-transplant infection or malignancy from immunosuppression
  • Sensitisation prolonging waiting time
  • Surgical/urological complications
  • Recurrent primary disease in the graft

Exam pearls

  • Refer early for pre-emptive transplantation — it offers the best outcomes
  • Living-donor transplantation beats deceased-donor and dialysis — explore it actively
  • Clear active infection and malignancy before immunosuppression
  • Update vaccinations (and avoid live vaccines) while still pre-transplant
  • Highly sensitised patients benefit from paired-exchange/desensitisation programmes

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.